In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits | With a $2.2 billion ...

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...

the FDA requested that manufacturers cease selling Zantac and any generic alternatives. Tens of thousands of cancer-stricken patients filed personal injury and product liability lawsuits against ...

Sanofi SA (NASDAQ:SASY) has announced an agreement in principle to settle approximately 4,000 lawsuits ... that Zantac, manufactured by Sanofi and other companies, may have caused cancer due ...

GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer, rather than proceed with a jury trial. The company said this morning it had reached a ...

The UK-based pharmaceutical company has been the target of numerous lawsuits for the past five years with plaintiffs alleging the popular heartburn medication causes cancer, and that the company ...

Carrie Joiner had claimed in her lawsuit that she developed colorectal cancer from a contaminant known as NDMA found in GSK's heartburn medication Zantac ... of times an ad is presented to ...

GSK’s shares rose by as much as 6.5% on Thursday before settling back slightly lower after it agreed a $2.2 billion settlement over lawsuits in the US, which alleged the drugmaker’s now ...

While the Company repeatedly claimed that scientific research did not support a correlation between Zantac and cancer ... What Is The Lawsuit About? The complaint filed in this class action ...

According to the complaint, in September and October 2019, GSK suspended its distribution of Zantac ... of cancer-stricken patients filed personal injury and product liability lawsuits against ...